Evidence map›Paper›PMID 24493323›Full record

ArticleInflammation2014

Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis.

Carmem Patrícia Barbosa, Alessandra Milene Ritter, Lorena Gimenez da Silva, Renata Grespan, Roberto Kenji Nakamura Cuman, Luzmarina Hernandes, Ciomar Aparecida Bersani-Amado

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carmem Patrícia BarbosaDepartment of Pharmacology and Therapeutics, State University of Maringá, Maringá, PR, Brazil.
Alessandra Milene Ritter
Lorena Gimenez da Silva
Renata Grespan
Roberto Kenji Nakamura Cuman
Luzmarina Hernandes
Ciomar Aparecida Bersani-Amado
Universidade Estadual de Maringá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the present study was to investigate the effects of monotherapy with simvastatin or ezetimibe compared with those of an ezetimibe + simvastatin combination on the histopathologic aspects of arthritis induced by Complete Freund's Adjuvant in rats. The characteristics of diarthrosis were analyzed 7 and 28 days after arthritis induction with regard to the regularity and integrity of articular cartilage, the presence of leukocytes in blood vessels at the inflammation site, and the cytokine levels in articular tissue. Monotherapy with simvastatin or ezetimibe and the ezetimibe + simvastatin combination effectively reduced the cytokine levels (interleukin-6 and tumor necrosis factor) and articular lesions that are characteristic of this experimental disease. Although the results did not reveal significant differences between the monotherapy and the combined therapy, they suggest that these drugs have considerable antiinflammatory properties, as reflected by an attenuation of articular cartilage lesions mediated by a reduction in the levels of proinflammatory cytokines.

Indexed as

Drug Therapy, CombinationAnimalsAnticholesteremic AgentsAnti-Inflammatory AgentsArthritisAzetidinesCartilage, ArticularDisease ProgressionEzetimibeFlow CytometryFreund's AdjuvantHydroxymethylglutaryl-CoA Reductase InhibitorsInflammationInterleukin-6MaleRatsAnticholesteremic AgentsAnti-Inflammatory AgentsAzetidinesEzetimibeFreund's AdjuvantHydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-6SimvastatinTumor Necrosis Factor-alpha

Identifiers

PMID24493323
OpenAlexW2017177757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.